Did you know you can now get UNLIMITED CE Hours for only $74.95?
Click Here to learn more.

CEU Course Description

This CEU course provides health care professionals working with the HIV-infected population information on pain syndrome and peripheral neuropathy; HIV-associated neurocognitive disorders; major depression and other depressive disorders; suicide risk; anxiety disorders; panic disorder; posttraumatic stress disorder; and insomnia.

Article Author:  U.S. Department of Health and Human Services
Exam writer:  Patricia Hocking-Walker, M.S. (Psychology)

CEU Course Objectives

1.  Enumerate risk factors for developing an HIV-associated neurocognitive disorder.

2.  Investigate the acceptable pharmacologic approaches to mild pain management according to the WHO.

3.  Examine the ARVs with the best CNS penetration.

4.  Identify which medication is considered first-line for HIV sensory neuropathy for its tolerability.

ACE credit is not offered for this course. A list of courses offering ACE credit can be found here.

CAADE Approval

This course does not have CAADE approval for CEUs.

Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional and licensed expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degrees of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff and their bios here.

*Questions regarding how to take a course, refunds, grievance policy and ADA policy can be found here.
*Questions regarding this course or need support? Contact us at support@quantumunitsed.com.

Added On: 01/06/2016